Nomenclature | LGR5 | LGR6 | MAS1 | MAS1L |
HGNC, UniProt | LGR5, O75473 | LGR6, Q9HBX8 | MAS1, P04201 | MAS1L, P35410 |
Endogenous agonists | R‐spondin‐2 (RSPO2, Q6UXX9) [277], R‐spondin‐1 (RSPO1, Q2MKA7) [277], R‐spondin‐3 (RSPO3, Q9BXY4) [277], R‐spondin‐4 (RSPO4, Q2I0M5) [277] | R‐spondin‐1 (RSPO1, Q2MKA7) [277, 426], R‐spondin‐2 (RSPO2, Q6UXX9) [277, 426], R‐spondin‐3 (RSPO3, Q9BXY4) [277, 426], R‐spondin‐4 (RSPO4, Q2I0M5) [277, 426] | – | – |
Agonists | – | – | angiotensin‐(1‐7) (AGT, P01019) [645] – Mouse | – |
Comments | The four R‐spondins can bind to LGR4, LGR5, and LGR6, which specifically associate with Frizzled and LDL receptor‐related proteins (LRPs), proteins that are activated by extracellular Wnt molecules and which then trigger canonical Wnt signalling to increase gene expression [277, 426]. | – | – | – |